A USFDA spokesperson, in an e-mailed statement said, "Following news reports about alleged lead levels in Maggi noodles made by Nestle and sold in the US, FDA tested a limited number of samples for lead contamination. FDA testing did not find any levels that present a public health concern for US consumers."
Meanwhile, a day after the government filed a class action suit against the company seeking Rs 640 crore in damages for alleged unfair trade practices, false labelling and misleading advertisements, Nestle India denied receiving an official notice.
"We are yet to receive an official notice about the complaint filed before the National Consumer Disputes Redressal Commission (NCDRC). Our current knowledge on this issue is only media reports. We shall be able to provide substantive response after we receive the official papers," Nestle said in a BSE filing.
Similarly, health regulators in the UK, Singapore, Canada, Australia and Vietnam have also cleared India-made Maggi as safe for human consumption.
In June, food safety regulator FSSAI had banned Maggi noodles in India, terming it as 'unsafe and hazardous' for consumption due to presence of lead beyond permissible limits. Nestle India too withdrew the product from the market.


Latest News  from Business News Desk